India to United States: Enoxaparin Export Trade Route

The India to United States Enoxaparin corridor is one of India's established pharmaceutical export routes, with 687 shipments documented worth a combined $88.1M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's enoxaparin manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $128.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #14 among India's top enoxaparin export destinations globally.

On the import side, key buyers of Indian enoxaparin in United States include FRESENIUS KABI USA, LLC, BE PHARMACEUTICALS INC, FRESENIUS KABI USA LLC and 7 others. FRESENIUS KABI USA, LLC is the single largest importer with 366 shipments valued at $38.8M USD.

India's enoxaparin exports to United States are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 456 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAND PHARMA LTD, BIOLOGICAL E. LIMITED, GLAND PHARMA LIMITED — together account for 96% of total trade value on this route. The average shipment value of $128.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as enoxaparin sodium injection usp 40mg/0.4ml and low molecular weight heparin enoxaparinsodium injection usp 40mg in 0 4ml prefilled syringe, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI USA, LLC is the largest importer with 366 shipments worth $38.8M USD — representing 44% of all enoxaparin imports from India on this route. A total of 10 buyers are active on this corridor.